Pulsed magnetic treatment for mild to moderate Alzheimer’s
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether a pulsed electromagnetic field (a non-drug device that uses magnetic pulses) can help people with mild to moderate Alzheimer’s. Participants typically stay on stable Alzheimer’s medicines and follow daily home treatments during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 50 or older
- Have a diagnosis of mild to moderate Alzheimer’s dementia
- Score between 16 and 26 on a memory test called MMSE
- If you take Alzheimer’s medicines like donepezil/other “cholinesterase inhibitors” or memantine, your dose must be stable for at least 3 months
- Have no epilepsy history or any condition that makes seizures more likely
- Have no metal implants in the head (some mouth metal is okay)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, noninvasive treatment that combines magnetic and electrical stimulation to target a specific brain network in people with mild Alzheimer's disease. It aims to slow memory decline and improve brain function.
This trial tests whether transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can help people with early Alzheimer's or mild cognitive impairment. It aims to see if the treatment is safe and effective for slowing memory decline.
This trial is testing whether a non-invasive brain stimulation treatment, called transcranial magnetic stimulation (using magnetic fields to activate brain cells), can help improve memory and thinking in people with Alzheimer's disease. It is a potential option for those looking to explore additional treatment approaches.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This study tests whether a noninvasive magnetic brain stimulation treatment can slow down cognitive decline in people with early Alzheimer's disease. You'll receive daily sessions over several weeks, and the goal is to see if it helps preserve memory and thinking skills.
This study tests a non-invasive brain stimulation technique called transcranial alternating current stimulation (tACS) to see if it can improve memory and thinking in people with early Alzheimer's disease. It may offer a new way to help manage symptoms.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.